跳转至内容

很抱歉,目前系统维护中。在此期间,网站下单功能无法使用。给您带来不便,深表歉意。如需其他帮助,请联系客户联络中心:400 620 3333。

Merck
CN
  • Interleukin-33 attenuates doxorubicin-induced cardiomyocyte apoptosis through suppression of ASK1/JNK signaling pathway.

Interleukin-33 attenuates doxorubicin-induced cardiomyocyte apoptosis through suppression of ASK1/JNK signaling pathway.

Biochemical and biophysical research communications (2017-10-03)
Yongwei Yao, Rong Chen, Chunyang Ying, Guohui Zhang, Tao Rui, Aibin Tao
摘要

Interleukin-33 (IL-33), a new member of the IL-1 cytokine family, has cardiac protective effect in many circumstances. The aims of present study are to assess whether IL-33 can protect cardiomyocytes from doxorubicin (DOX)-induced apoptosis and the mechanism involved in the protection. Cardiomyocytes derived from either wild-type or c-Jun N-terminal kinase deficient (JNK

材料
货号
品牌
产品描述

Sigma-Aldrich
MISSION® esiRNA, targeting human MAP3K5
登录查看公司和协议定价
货号包装规格是否有货价格数量
20 μg
预计发货时间 2025年6月27日
详情...
¥3,096.05
50 μg
预计发货时间 2025年6月27日
详情...
¥5,521.21